Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Aug
4
2023
 FDA Announces Public Meeting to Modernize Recalls Keller and Heckman LLP
Aug
4
2023
 Holy Pulmonary Hypertension, Batman: Method of Treatment Not Constrained by Safety and Efficacy McDermott Will & Emery
Aug
3
2023
 OECD Publishes Consensus Document on Environmental Considerations for the Release of Transgenic Plants Bergeson & Campbell, P.C.
Aug
3
2023
 Good News, Bad News: Congress Wants to Help the Hemp Industry Bradley Arant Boult Cummings LLP
Aug
3
2023
 The Secret to Success: Protecting Your Cannabis Trade Secrets Bradley Arant Boult Cummings LLP
Aug
2
2023
 EC Committee Updates Guidance on the Safety Assessment of Nanomaterials in Cosmetics Bergeson & Campbell, P.C.
Aug
2
2023
 AAFCO Approves New Model Pet Food and Specialty Pet Food Regulations for Pet Food Packaging Keller and Heckman LLP
Aug
2
2023
 FDA Warns “Natural” Birth Control Company: Three Takeaways from the NOV Letter Mintz
Aug
1
2023
 BETO Will Host Bioenergy Cybersecurity Workshop on September 11, 2023 Bergeson & Campbell, P.C.
Aug
1
2023
 Lawsuit Against Starbucks Dismissed; Sanctions Against Plaintiff’s Attorney Considered Keller and Heckman LLP
Aug
1
2023
 Unpacking Averages: Analyzing the Relationship Between MDRs and Recalls Epstein Becker & Green, P.C.
Aug
1
2023
 Cancer Moonshot Initiative Adds Precision Surgery Effort Foley & Lardner LLP
Aug
1
2023
 EPA Adds Nine PFAS Chemicals to The Toxics Release Inventory Reporting List Babst, Calland, Clements & Zomnir, P.C.
Aug
1
2023
 Triaging Health Risks in the Cosmetic World: FDA Says Let’s Start with Tattoo Inks Polsinelli PC
Aug
1
2023
 FDA’s LDT Proposed Rule Heads to the White House Epstein Becker & Green, P.C.
Aug
1
2023
 Podcast: Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now? – Diagnosing Health Care [Podcast] Epstein Becker & Green, P.C.
Aug
1
2023
 Washington State Proposes Sweeping Changes to Key Greenhouse Gas Regulation Beveridge & Diamond PC
Jul
31
2023
 UCB, Inc. v. Actavis Laboratories UT, Inc. No. 2021-1924, (Fed. Cir. Apr. 12, 2023) Sheppard, Mullin, Richter & Hampton LLP
Jul
31
2023
 Proposed Class Action Dismissed Over Lack of Standing Keller and Heckman LLP
Jul
31
2023
 The 2024 Proposed Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know ArentFox Schiff LLP
Jul
31
2023
 Bipartisan Group of Representatives Calls on EPA to Assess the Risks of PFAS in Fluorinated Containers Bergeson & Campbell, P.C.
Jul
31
2023
 APHIS 2022 Impact Report Includes Summary of Biotechnology Activities Bergeson & Campbell, P.C.
Jul
28
2023
 Will Mississippi’s List of Qualifying Conditions for Medical Cannabis Soon Be Expanded? Bradley Arant Boult Cummings LLP
Jul
28
2023
 Amendment to House Bill Threatens Funding of Organic Standards Keller and Heckman LLP
Jul
27
2023
 CMS Proposes Changes to Medicare Provider Enrollment Rules Polsinelli PC
Jul
27
2023
 New Medicare Marketing Definition Squire Patton Boggs (US) LLP
Jul
27
2023
 CMS Proposes Remedy for 340B-Acquired Drug Payment Policy for CY 2018-2022 Foley & Lardner LLP
Jul
27
2023
 FDA Maintains Focus on “Intended Use” for Software-Enabled Medical Devices Sheppard, Mullin, Richter & Hampton LLP
Displaying 1961 - 1988 of 12191
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters